Brief: Genprex Announces Ip Australia's Intent To Grant Patent For Reqorsa® Gene Therapy
10/02/2026 13:56
Feb 10 (Reuters) - Genprex Inc GNPX.O: GENPREX ANNOUNCES IP AUSTRALIA'S INTENT TO GRANT PATENT FOR REQORSA® GENE THERAPY IN COMBINATION WITH PD-L1 ANTIBODIES TO TREAT CANCERS Source text: ID:nPn1zsPPKa Further company coverage: GNPX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genprex
See all newsBrief: Genprex Announces Collaboration With Roche Diagnostics For Biomarker Assay Validation Studies
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Genprex Announces Ip Australia's Intent To Grant Patent For Reqorsa® Gene Therapy